BASE Demoprojekt

Dies ist ein Demoprojekt. Es dient Ihnen als Grundlage für den Aufbau individueller Seiten mit Weblication® CMS.

Die Seitenstruktur, das Layout und die von den Redakteuren nutzbaren Seitenelemente können Sie frei definieren.

Table of Contents

Insight into the most comprehensive Market Report "Pharma Automation Markets 2020".

 
  • 1. EXECUTIVE SUMMARY
    1
    • 1.1 Pharmaceutical Automation Markets
      3
    • 1.2 Technology Trends
      7
    • 1.3 Strategies
      12
  • 2 AIM AND SCOPE, DEFINITIONS, EXCLUSIONS
    17
    • 2.1 Aim and Scope
      19
    • 2.2 Definitions and Exclusions
      20
      • 2.2.1 Country Definitions and their Attribution to Regions
        20
      • 2.2.2 Production Values and Shipments
        21
      • 2.2.3 Capital Expenditures
        22
      • 2.2.4 Production Investments
        25
      • 2.2.5 Production Project Costs
        27
      • 2.2.6 Production Operating Expenses
        28
    • 2.3 Segmentation of Automation Markets
      28
  • 3 METHODOLOGY, ASSUMPTIONS AND SOURCES OF INFORMATION
    37
    • 3.1 Methodology
      39
    • 3.2 Important Assumptions
      41
    • 3.3 Sources of Information
      43
  • 4 AUTOMATION MARKETS FOR THE PHARMACEUTICAL INDUSTRY: OVERVIEW (100 PAGES)
    49
    • 4.1 Pharmaceutical Industry - Basics
      51
      • 4.1.1 Scope and Definitions
        51
      • 4.1.2 Industry Codes of Relevance
        56
      • 4.1.3 Processes Involved
        58
      • 4.1.4 Overall Trends in the Pharmaceutical Industry
        60
      • 4.1.5 Stimulating Factors and Barriers for Pharmaceutical Markets
        64
    • 4.2 Worldwide Production Development in the Pharmaceutical Industry until 2020
      66
      • 4.2.1 Overview
        66
      • 4.2.2 Active Pharmaceutical Ingredients (APIs)
        66
      • 4.2.3 Pharmaceutical Preparations (excl. APIs)s
        67
      • 4.2.4 Therapeutic Drugs
        68
      • 4.2.5 Diagnostic Drugs
        69
    • 4.3 Worldwide Development of Capital Expenditures in the Pharmaceutical Industry until 2020
      75
      • 4.3.1 Overview
        75
      • 4.3.2 Capital Expenditures for Synthetic & Botanical Pharmaceuticals
        77
      • 4.3.3 Capital Expenditures for Biologic Pharmaceuticals
        78
      • 4.3.4 Production Investments in Pharmaceuticals
        79
      • 4.3.5 Production Investments by Types of Investments
        80
      • 4.3.6 External Project and Maintenance Expenditures by Supplier Structure
        80
    • 4.4 Worldwide Market Development of Plant-Related Products and Services in the Pharmaceutical Industry until 2020
      91
      • 4.4.1 Share of Automation in the Pharmaceutical Industry: Project Costs
        91
      • 4.4.2 Plant Trends in the Pharmaceutical Industry
        91
      • 4.4.3 Automation Trends in the Pharmaceutical Industry
        93
      • 4.4.4 Worldwide Market Development of Automation for the Pharmaceutical Industry until 2020: Total Market/External Demand
        99
      • 4.4.5 Worldwide Market Development of Automation for the Pharmaceutical Industry until 2020: Total Market/External Demand
        100
      • 4.4.6 Worldwide Market Development of Automation for the Pharmaceutical Industry until 2020: Project Phase
        100
      • 4.4.7 Worldwide Market Development of Automation for the Pharmaceutical Industry until 2020: Operation Phase
        101
      • 4.4.8 Worldwide Market Development of Automation for the Pharmaceutical Industry until 2020 by Core and Auxiliary Processes
        101
      • 4.4.9 Worldwide Market Development of Automation Hardware for the Pharmaceutical Industry until 2020
        113
      • 4.4.10 Worldwide Market Development of Control Level Hardware for the Pharmaceutical Industry until 2020
        113
      • 4.4.11 Worldwide Market Development of Instrumentation Level Hardware for the Pharmaceutical Industry until 2020
        114
      • 4.4.12 Worldwide Market Development of Automation Software for the Pharmaceutical Industry until 2020
        115
      • 4.4.13 Worldwide Market Development of Automation Services for the Pharmaceutical Industry until 2020
        115
      • 4.4.14 Worldwide Market Development of Automation for the Pharmaceutical Industry until 2020 by Pharmaceutical Industry Subsectors until 2020
        116
      • 4.4.15 Worldwide Market Development of Automation for the Pharmaceutical Industry in 2010 by Distribution Channels
        117
  • 5 AUTOMATION MARKETS FOR FORMULATION & PACKAGING OF SYNTHETIC PATENTED DRUGS
    145
    • 5.1 Worldwide Production Development of Synthetic Patented Drugs until 2020
      147
    • 5.2 Worldwide Development of Capital Expenditures and Production Investments for Formulation and Packaging of Synthetic Patented Drugs until 2020
      147
    • 5.3 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Patented Drugs until 2020
      154
      • 5.3.1 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Patented Drugs until 2020: Total Market/External Demand
        154
      • 5.3.2 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Patented Drugs until 2020: Total Market/External and Internal Demand
        155
      • 5.3.3 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Patented Drugs until 2020: Project Phase
        155
      • 5.3.4 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Patented Drugs until 2020: Operation Phase
        156
      • 5.3.5 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Patented Drugs until 2020 by Core and Auxiliary Processes
        156
      • 5.3.6 Worldwide Market Development of Automation Hardware for Formulation and Packaging of Synthetic Patented Drugs until 2020
        169
      • 5.3.7 Worldwide Market Development of Control Level Hardware for Formulation and Packaging of Synthetic Patented Drugs until 2020
        169
      • 5.3.8 Worldwide Market Development of Instrumentation Level Hardware for Formulation and Packaging of Synthetic Patented Drugs until 2020
        170
      • 5.3.9 Worldwide Market Development of Automation Software for Formulation and Packaging of Synthetic Patented Drugs until 2020
        171
      • 5.3.10 Worldwide Market Development of Automation Services for Formulation and Packaging of Synthetic Patented Drugs until 2020
        171
  • 6 AUTOMATION MARKETS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF SYNTHETIC PATENTED DRUGS
    195
    • 6.1 Worldwide Production Development of APIs for Synthetic Patented Drugs until 2020 (Open Market)
      197
    • 6.2 Worldwide Development of Capital Expenditures and Production Investments for APIs of Synthetic Patented Drugs until 2020
      197
    • 6.3 Worldwide Market Development of Automation for APIs of Synthetic Patented Drugs until 2020
      204
      • 6.3.1 Worldwide Market Development of Automation for APIs of Synthetic Patented Drugs until 2020: Total Market/External Demand
        204
      • 6.3.2 Worldwide Market Development of Automation for APIs of Synthetic Patented Drugs until 2020: Total Market/External and Internal Demand
        205
      • 6.3.3 Worldwide Market Development of Automation for APIs of Synthetic Patented Drugs until 2020: Project Phase
        205
      • 6.3.4 Worldwide Market Development of Automation for APIs of Synthetic Patented Drugs until 2020: Operation Phase
        206
      • 6.3.5 Worldwide Market Development of Automation for APIs of Synthetic Patented Drugs until 2020 by Core and Auxiliary Processes
        206
      • 6.3.6 Worldwide Market Development of Automation Hardware for APIs of Synthetic Patented Drugs until 2020
        219
      • 6.3.7 Worldwide Market Development of Control Level Hardware for APIs of Synthetic Patented Drugs until 2020
        219
      • 6.3.8 Worldwide Market Development of Instrumentation Level Hardware for APIs of Synthetic Patented Drugs until 2020
        220
      • 6.3.9 Worldwide Market Development of Automation Software for APIs of Synthetic Patented Drugs until 2020
        221
      • 6.3.10 Worldwide Market Development of Automation Services for APIs of Synthetic Patented Drugs until 2020
        221
  • 7 AUTOMATION MARKETS FOR FORMULATION & PACKAGING OF SYNTHETIC GENERIC DRUGS
    245
    • 7.1 Worldwide Production Development of Synthetic Generic Drugs until 2020
      247
    • 7.2 Worldwide Development of Capital Expenditures and Production Investments for Formulation and Packaging of Synthetic Generic Drugs until 2020
      247
    • 7.3 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Generic Drugs until 2020
      254
      • 7.3.1 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Generic Drugs until 2020: Total Market/External Demand
        254
      • 7.3.2 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Generic Drugs until 2020: Total Market/External and Internal Demand
        255
      • 7.3.3 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Generic Drugs until 2020: Project Phase
        255
      • 7.3.4 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Generic Drugs until 2020: Operation Phase
        256
      • 7.3.5 Worldwide Market Development of Automation for Formulation and Packaging of Synthetic Generic Drugs until 2020 by Core and Auxiliary Processes
        256
      • 7.3.6 Worldwide Market Development of Automation Hardware for Formulation and Packaging of Synthetic Generic Drugs until 2020
        269
      • 7.3.7 Worldwide Market Development of Control Level Hardware for Formulation and Packaging of Synthetic Generic Drugs until 2020
        269
      • 7.3.8 Worldwide Market Development of Instrumentation Level Hardware for Formulation and Packaging of Synthetic Generic Drugs until 2020
        270
      • 7.3.9 Worldwide Market Development of Automation Software for Formulation and Packaging of Synthetic Generic Drugs until 2020
        271
      • 7.3.10 Worldwide Market Development of Automation Services for Formulation and Packaging of Synthetic Generic Drugs until 2020
        271
  • 8 AUTOMATION MARKETS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF SYNTHETIC GENERIC DRUGS
    295
    • 8.1 Worldwide Production Development of APIs for Synthetic Generic Drugs until 2020 (Open Market)
      297
    • 8.2 Worldwide Development of Capital Expenditures and Production Investments for APIs of Synthetic Generic Drugs until 2020
      297
    • 8.3 Worldwide Market Development of Automation for APIs of Synthetic Generic Drugs until 2020
      304
      • 8.3.1 Worldwide Market Development of Automation for APIs of Synthetic Generic Drugs until 2020: Total Market/External Demand
        304
      • 8.3.2 Worldwide Market Development of Automation for APIs of Synthetic Generic Drugs until 2020: Total Market/External and Internal Demand
        305
      • 8.3.3 Worldwide Market Development of Automation for APIs of Synthetic Generic Drugs until 2020: Project Phase
        305
      • 8.3.4 Worldwide Market Development of Automation for APIs of Synthetic Generic Drugs until 2020: Operation Phase
        306
      • 8.3.5 Worldwide Market Development of Automation for APIs of Synthetic Generic Drugs until 2020 by Core and Auxiliary Processes
        306
      • 8.3.6 Worldwide Market Development of Automation Hardware for APIs of Synthetic Generic Drugs until 2020
        319
      • 8.3.7 Worldwide Market Development of Control Level Hardware for APIs of Synthetic Generic Drugs until 2020
        319
      • 8.3.8 Worldwide Market Development of Instrumentation Level Hardware for APIs of Synthetic Generic Drugs until 2020
        320
      • 8.3.9 Worldwide Market Development of Automation Software for APIs of Synthetic Generic Drugs until 2020
        321
      • 8.3.10 Worldwide Market Development of Automation Services for APIs of Synthetic Generic Drugs until 2020
        321
  • 9 AUTOMATION MARKETS FOR TRADITIONAL DIAGNOSTIC DRUGS
    345
    • 9.1 Worldwide Production Development of Traditional Diagnostic Drugs until 2020
      347
    • 9.2 Worldwide Development of Capital Expenditures and Production Investments for Traditional Diagnostic Drugs until 2020
      347
    • 9.3 Worldwide Market Development of Automation for Traditional Diagnostic Drugs until 2020
      354
      • 9.3.1 Worldwide Market Development of Automation for Traditional Diagnostic Drugs until 2020: Total Market/External Demand
        354
      • 9.3.2 Worldwide Market Development of Automation for Traditional Diagnostic Drugs until 2020: Total Market/External and Internal Demand
        355
      • 9.3.3 Worldwide Market Development of Automation for Traditional Diagnostic Drugs until 2020: Project Phase
        355
      • 9.3.4 Worldwide Market Development of Automation for Traditional Diagnostic Drugs until 2020: Operation Phase
        356
      • 9.3.5 Worldwide Market Development of Automation for Traditional Diagnostic Drugs until 2020 by Core and Auxiliary Processes
        356
      • 9.3.6 Worldwide Market Development of Automation Hardware for TraditionalDiagnostic Generic Drugs until 2020
        369
      • 9.3.7 Worldwide Market Development of Control Level Hardware for Traditional Diagnostic Generic Drugs until 2020
        369
      • 9.3.8 Worldwide Market Development of Instrumentation Level Hardware for Traditional Diagnostic Drugs until 2020
        370
      • 9.3.9 Worldwide Market Development of Automation Software for Traditional Diagnostic Drugs until 2020
        371
      • 9.3.10 Worldwide Market Development of Automation Services for Traditional Diagnostic Drugs until 2020
        371
  • 10 AUTOMATION MARKETS FOR FORMULATION & PACKAGING OF BIOPHARMACEUTICAL PATENTED DRUGS
    395
    • 10.1 Worldwide Production Development of Biopharmaceutical Patented Drugs until 2020
      397
    • 10.2 Worldwide Development of Capital Expenditures and Production Investments for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
      397
    • 10.3 Worldwide Market Development of Automation for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
      404
      • 10.3.1 Worldwide Market Development of Automation for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020: Total Market/External Demand
        404
      • 10.3.2 Worldwide Market Development of Automation for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020: Total Market/External and Internal Demand
        405
      • 10.3.3 Worldwide Market Development of Automation for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020: Project Phase
        405
      • 10.3.4 Worldwide Market Development of Automation for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020: Operation Phase
        406
      • 10.3.5 Worldwide Market Development of Automation for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020 by Core and Auxiliary Processes
        406
      • 10.3.6 Worldwide Market Development of Automation Hardware for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
        419
      • 10.3.7 Worldwide Market Development of Control Level Hardware for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
        419
      • 10.3.8 Worldwide Market Development of Instrumentation Level Hardware for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
        420
      • 10.3.9 Worldwide Market Development of Automation Software for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
        421
      • 10.3.10 Worldwide Market Development of Automation Services for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
        421
  • 11 AUTOMATION MARKETS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF BIOPHARMACEUTICAL PATENTED DRUGS
    445
    • 11.1 Worldwide Production Development of APIs for Biopharmaceutical Patented Drugs until 2020 (Open Market)
      447
    • 11.2 Worldwide Development of Capital Expenditures and Production Investments for APIs of Biopharmaceutical Patented Drugs until 2020
      447
    • 11.3 Worldwide Market Development of Automation for APIs of Biopharmaceutical Patented Drugs until 2020
      454
      • 11.3.1 Worldwide Market Development of Automation for APIs of Biopharmaceutical Patented Drugs until 2020: Total Market/External Demand
        454
      • 11.3.2 Worldwide Market Development of Automation for APIs of Biopharmaceutical Patented Drugs until 2020: Total Market/External and Internal Demand
        455
      • 11.3.3 Worldwide Market Development of Automation for APIs of Biopharmaceutical Patented Drugs until 2020: Project Phase
        455
      • 11.3.4 Worldwide Market Development of Automation for APIs of Biopharmaceutical Patented Drugs until 2020: Operation Phase
        456
      • 11.3.5 Worldwide Market Development of Automation for APIs of Biopharmaceutical Patented Drugs until 2020 by Core and Auxiliary Processes
        456
      • 11.3.6 Worldwide Market Development of Automation Hardware for APIs of Biopharmaceutical Patented Drugs until 2020
        469
      • 11.3.7 Worldwide Market Development of Control Level Hardware for APIs of Biopharmaceutical Patented Drugs until 2020
        469
      • 11.3.8 Worldwide Market Development of Instrumentation Level Hardware for APIs of Biopharmaceutical Patented Drugs until 2020
        470
      • 11.3.9 Worldwide Market Development of Automation Software for APIs of Biopharmaceutical Patented Drugs until 2020
        471
      • 11.3.10 Worldwide Market Development of Automation Services for APIs of Biopharmaceutical Patented Drugs until 2020
        471
  • 12 AUTOMATION MARKETS FOR FORMULATION & PACKAGING OF BIOSIMILAR DRUGS
    495
    • 12.1 Worldwide Production Development of Biosimilar Drugs until 2020
      497
    • 12.2 Worldwide Development of Capital Expenditures and Production Investments for Formulation and Packaging of Biosimilar Drugs until 2020
      497
    • 12.3 Worldwide Market Development of Automation for Formulation and Packaging of Biosimilar Drugs until 2020
      504
      • 12.3.1 Worldwide Market Development of Automation for Formulation and Packaging of Biosimilar Drugs until 2020: Total Market/External Demand
        504
      • 12.3.2 Worldwide Market Development of Automation for Formulation and Packaging of Biosimilar Drugs until 2020: Total Market/External and Internal Demand
        505
      • 12.3.3 Worldwide Market Development of Automation for Formulation and Packaging of Biosimilar Drugs until 2020: Project Phase
        505
      • 12.3.4 Worldwide Market Development of Automation for Formulation and Packaging of Biosimilar Drugs until 2020: Operation Phase
        506
      • 12.3.5 Worldwide Market Development of Automation for Formulation and Packaging of Biosimilar Drugs until 2020 by Core and Auxiliary Processes
        506
      • 12.3.6 Worldwide Market Development of Automation Hardware for Formulation and Packaging of Biosimilar Drugs until 2020
        519
      • 12.3.7 Worldwide Market Development of Control Level Hardware for Formulation and Packaging of Biosimilar Drugs until 2020
        519
      • 12.3.8 Worldwide Market Development of Instrumentation Level Hardware for Formulation and Packaging of Biosimilar Drugs until 2020
        520
      • 12.3.9 Worldwide Market Development of Automation Software for Formulation and Packaging of Biosimilar Drugs until 2020
        521
      • 12.3.10 Worldwide Market Development of Automation Services for Formulation and Packaging of Biosimilar Drugs until 2020
        521
  • 13 AUTOMATION MARKETS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF BIOSIMILAR DRUGS
    545
    • 13.1 Worldwide Production Development of APIs for Biosimilar Drugs until 2020 (Open Market)
      547
    • 13.2 Worldwide Development of Capital Expenditures and Production Investments for APIs of Biosimilar Drugs until 2020
      547
    • 13.3 Worldwide Market Development of Automation for APIs of Biosimilar Drugs until 2020
      554
      • 13.3.1 Worldwide Market Development of Automation for APIs of Biosimilar Drugs until 2020: Total Market/External Demand
        554
      • 13.3.2 Worldwide Market Development of Automation for APIs of Biosimilar Drugs until 2020: Total Market/External and Internal Demand
        555
      • 13.3.3 Worldwide Market Development of Automation for APIs of Biosimilar Drugs until 2020: Project Phase
        555
      • 13.3.4 Worldwide Market Development of Automation for APIs of Biosimilar Drugs until 2020: Operation Phase
        556
      • 13.3.5 Worldwide Market Development of Automation for APIs of Biosimilar Drugs until 2020 by Core and Auxiliary Processes
        556
      • 13.3.6 Worldwide Market Development of Automation Hardware for APIs of Biosimilar Drugs until 2020
        569
      • 13.3.7 Worldwide Market Development of Control Level Hardware for APIs of Biosimilar Drugs until 2020
        569
      • 13.3.8 Worldwide Market Development of Instrumentation Level Hardware for APIs of Biosimilar Drugs until 2020
        570
      • 13.3.9 Worldwide Market Development of Automation Software for APIs of Biosimilar Drugs until 2020
        571
      • 13.3.10 Worldwide Market Development of Automation Services for APIs of Biosimilar Drugs until 2020
        571
  • 14 AUTOMATION MARKETS FOR MOLECULAR DIAGNOSTIC DRUGS
    595
    • 14.1 Worldwide Production Development of Molecular Diagnostic Drugs until 2020
      597
    • 14.2 Worldwide Development of Capital Expenditures and Production Investments for Molecular Diagnostic Drugs until 2020
      597
    • 14.3 Worldwide Market Development of Automation for Molecular Diagnostic Drugs until 2020
      604
      • 14.3.1 Worldwide Market Development of Automation for Molecular Diagnostic Drugs until 2020: Total Market/External Demand
        604
      • 14.3.2 Worldwide Market Development of Automation for Molecular Diagnostic Drugs until 2020: Total Market/External and Internal Demand
        605
      • 14.3.3 Worldwide Market Development of Automation for Molecular Diagnostic Drugs until 2020: Project Phase
        605
      • 14.3.4 Worldwide Market Development of Automation for Molecular Diagnostic Drugs until 2020: Operation Phase
        606
      • 14.3.5 Worldwide Market Development of Automation for Molecular Diagnostic Drugs until 2020 by Core and Auxiliary Processes
        606
      • 14.3.6 Worldwide Market Development of Automation Hardware for Molecular Diagnostic Generic Drugs until 2020
        619
      • 14.3.7 Worldwide Market Development of Control Level Hardware for Molecular Diagnostic Generic Drugs until 2020
        619
      • 14.3.8 Worldwide Market Development of Instrumentation Level Hardware for Molecular Diagnostic Drugs until 2020
        620
      • 14.3.9 Worldwide Market Development of Automation Software for Molecular Diagnostic Drugs until 2020
        621
      • 14.3.10 Worldwide Market Development of Automation Services for Molecular Diagnostic Drugs until 2020
        621
  • 15 AUTOMATION MARKETS FOR TRADITIONAL BIOLOGICALS
    645
    • 15.1 Worldwide Production Development of Traditional Biologicals until 2020
      647
    • 15.2 Worldwide Development of Capital Expenditures and Production Investments for Traditional Biologicals until 2020
      647
    • 15.3 Worldwide Market Development of Automation for Traditional Biologicals until 2020
      654
      • 15.3.1 Worldwide Market Development of Automation for Traditional Biologicals until 2020: Total Market/External Demand
        654
      • 15.3.2 Worldwide Market Development of Automation for Traditional Biologicals until 2020: Total Market/External and Internal Demand
        655
      • 15.3.3 Worldwide Market Development of Automation for Traditional Biologicals until 2020: Project Phase
        655
      • 15.3.4 Worldwide Market Development of Automation for Traditional Biologicals until 2020: Operation Phase
        656
      • 15.3.5 Worldwide Market Development of Automation for Traditional Biologicals until 2020 by Core and Auxiliary Processes
        656
      • 15.3.6 Worldwide Market Development of Automation Hardware for Traditional Biologicals Drugs until 2020
        669
      • 15.3.7 Worldwide Market Development of Control Level Hardware for Traditional Biologicals until 2020
        669
      • 15.3.8 Worldwide Market Development of Instrumentation Level Hardware for Traditional Biologicals until 2020
        670
      • 15.3.9 Worldwide Market Development of Automation Software for Traditional Biologicals until 2020
        671
      • 15.3.10 Worldwide Market Development of Automation Services for Traditional Biologicals until 2020
        671
  • 16 AUTOMATION MARKETS FOR OUTSOURCED AUXILIARY PROCESSES
    695
    • 16.1 Basics and Definitions
      697
    • 16.2 Worldwide Market Development of Automation for Outsourced Auxiliary Processes until 2020
      698
      • 16.2.1 Worldwide Market Development of Automation for Outsourced Auxiliary Processes until 2020: Total Market/External Demand
        698
      • 16.2.2 Worldwide Market Development of Automation for Outsourced Auxiliary Processes until 2020: Total Market/External and Internal Demand
        699
      • 16.2.3 Worldwide Market Development of Automation for Outsourced Auxiliary Processes until 2020: Project Phase
        699
      • 16.2.4 Worldwide Market Development of Automation for Outsourced Auxiliary Processes until 2020: Operation Phase
        700
      • 16.2.5 Worldwide Market Development of Automation for Outsourced Auxiliary Processes until 2020 by Auxiliary Processes
        700
      • 16.2.6 Worldwide Market Development of Automation Hardware for Outsourced Auxiliary Processes until 2020
        713
      • 16.2.7 Worldwide Market Development of Control Level Hardware for Outsourced Auxiliary Processes until 2020
        713
      • 16.2.8 Worldwide Market Development of Instrumentation Level Hardware for Outsourced Auxiliary Processes until 2020
        714
      • 16.2.9 Worldwide Market Development of Automation Software for Outsourced Auxiliary Processes until 2020
        715
      • 16.2.10 Worldwide Market Development of Automation Services for Outsourced Auxiliary Processes until 2020
        715
 

Table of Contents

Insight into the most valuable Pharma Automation Markets 2020 Report

Summaries

Please contact us for our Pharma Automation Markets 2020 Report
- Sample Summaries

Facts + Figures
 
 
 

© INTECHNO CONSULTING, Basle (Switzerland), 2012-2016



Market reports by

ITC Logo